Roche announces board and exec changes

At its December meeting today, the board of directors of Swiss pharma giant Roche (ROG: SIX) approved to propose some major board changes at the Annual General Meeting, which will take place on March 14, 2023.

As previously announced in July 2022, Christoph Franz has decided not to seek re-election as chairman. The board of directors will propose Severin Schwan as the new chairman at the Annual General Meeting in 2023, and has appointed Thomas Schinecker as the new Roche Group chief executive effective March 14, 2023.

Bill Anderson, who is currently chief executive of Roche Pharmaceuticals and member of the corporate executive committee, has decided to pursue opportunities outside of Roche effective December 31 this year. No indications of his future plans were divulged. A successor will be appointed by March 2023.